Participated and spoke at “Innovation Leaders Summit 2023” (Dec.5)).
Participated in the “Innovation Leaders Summit 2023” held at Toranomon Hills Mori Tower from December 4 to 7, 2023, and spoke the “NEDO Dream Pitch” on the 5th.
Events（CY2022-）The New Web Site Is Under Construction
(July 5, 2023~)
Towards a Future That Creates Abundance for Humanity
The global Pharma industry is said to be a huge and growing market in the world.
We're a stem cell bio-venture company conducting research and development.
-
PHILOSOPHY
The goal is to illuminate the future of the humanity with the latest medical science that utilizes genetic research and biotechnology, with drugs that are appreciate for individual patients and have fewer side effects.
-
MESSAGE
Our research and development professionals have built a top-level development system, and are working every day to create better medicines and a better world.
-
PROFILE
As a global company, we'll partner with research institutions and Pharma companies to research cutting-edge medicines as well as to make a better world by developing new therapies.
NEWS
-
News
Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).
-
News
Notice of website maintenance
-
IR
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).
-
Press Release
We will start joint research with Mochida Pharmaceutical Co. ,Ltd
-
Press Release
We reported the financial results at the regular general meeting of shareholders.
-
Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).
-
Notice of website maintenance
-
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).
-
“ACHIEVEMENTS” Page has been updated.
-
Participated in “Japan Healthcare Venture Summit 2020” (Oct. 14-16).
-
We will start joint research with Mochida Pharmaceutical Co. ,Ltd
-
We reported the financial results at the regular general meeting of shareholders.
-
Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding
-
Received the Excellence Award in the “16th Innovation Research and Development Grant” by Senshu Ikeda Bank, Ltd.
-
Notice Concerning Issuance of New Shares by way of Third-Party Allotment (A-2 Series)
-
We will start joint research with Mochida Pharmaceutical Co. ,Ltd
-
Research and development of exosomes will be resumed.
-
Poster presentation at “18th Annual Meeting of the Japanese Society for Regenerative Medicine” (Mar. 21-23).
-
Exhibited and spoke at “Innovation Leaders Summit 2016” (Oct. 24-25).
-
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).
-
Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding
-
Notice Concerning Issuance of New Shares by way of Third-Party Allotment (A-2 Series)
-
Notice Concerning Issuance of New Shares by way of Third-Party Allotment (A-1 Series)
PROJECTS
We, bio-venture companies, support people's healthy and secure lives through prevention and treatment of diseases directly related to health.
We develop and manufacture regenerative medicine products under strict legal regulations including the Pharmaceutical Affairs Law, which is essential to ensure the efficacy and safety of such products.
-
Cell Therapy
Cell therapy is a treatment method that uses your own cells or the cells of others to treat diseases. Oligogen is developing a new treatment for neurological diseases for which there has been no treatment using its proprietary neural stem cells, OligoGenie.
-
Exosome Therapy
Exosomes are very small vesicles secreted by cells and are beginning to be applied in cancer diagnosis and disease treatment. Oligogen is developing an exosome preparation that may be useful in the treatment of neurological diseases and plans to apply it to the treatment of neurological diseases such as Alzheimer's disease and multiple sclerosis.
-
Drug Discovery
Drug discovery is the process of finding compounds and chemicals (sometimes called seeds or lead compounds) that will become the source of pharmaceuticals until they are marketed as products. Oligogen is developing a drug screen system to discover compounds and chemicals for the treatment of demyelinating diseases and neurodegenerative diseases using neural stem cell OligoGenie.
ACHIEVEMENTS
Participated in the “Kyoto City Growth Industry Creation Center (ACT Kyoto) 10th Anniversary Forum” (Nov.7)
On November 7, 2023, our CEO, Mr. Kido, gave a short presentation at the “Kyoto City Growth Industry Creation Center (ACT Kyoto) 10th Anniversary Forum“.
Events（CY2022-）
Participated and spoke at “KLSAP2023 Pitch Event” (Jul. 14).
Our representative participated in the “KLSAP2023 Pitch Event” held at Creative Lab Kobe on July 14, 2023, and spoke at the “Pitch Competition”.
Events（CY2022-）